Medicine & Life Sciences
Natural Killer Cells
100%
Chimeric Antigen Receptors
88%
T-Lymphocytes
86%
Fetal Blood
78%
Allogeneic Cells
72%
Stem Cell Transplantation
71%
Transplants
71%
Graft vs Host Disease
66%
Transplantation
56%
Tissue Donors
55%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
55%
Cell- and Tissue-Based Therapy
53%
Leukemia
51%
Hematopoietic Stem Cell Transplantation
49%
Acute Myeloid Leukemia
48%
Immunotherapy
45%
Survival
34%
Neoplasms
33%
Cell Transplantation
32%
Recurrence
31%
Stem Cells
29%
Hematologic Neoplasms
29%
Unrelated Donors
28%
Cytogenetics
27%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
23%
Busulfan
22%
Imatinib Mesylate
21%
Multiple Myeloma
21%
KIR Receptors
21%
Cyclophosphamide
21%
Regulatory T-Lymphocytes
21%
Myeloid Leukemia
21%
B-Lymphocytes
19%
Progression-Free Survival
19%
Therapeutics
19%
Antigens
18%
Haploidentical Transplantation
18%
Hematopoietic Stem Cells
18%
GATA2 Deficiency
17%
Vaccination
17%
fludarabine
16%
Cytokine Release Syndrome
16%
BK Virus
16%
Cytomegalovirus
16%
Leukemia, Myeloid, Chronic Phase
15%
Protein-Tyrosine Kinases
15%
Blood Cells
15%
Peptides
15%
Mortality
14%
Interleukin-15
14%